Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
134.05B
Market cap134.05B
Price-Earnings ratio
36.44
Price-Earnings ratio36.44
Dividend yield
0.70%
Dividend yield0.70%
Average volume
4.31M
Average volume4.31M
High today
$190.45
High today$190.45
Low today
$185.38
Low today$185.38
Open price
$186.69
Open price$186.69
Volume
4.46M
Volume4.46M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$171.00
52 Week low$171.00

Stock Snapshot

As of today, Danaher(DHR) shares are valued at $189.60. The company's market cap stands at 134.05B, with a P/E ratio of 36.44 and a dividend yield of 69.6%.

As of 2026-03-31, Danaher(DHR) stock has fluctuated between $185.38 and $190.45. The current price stands at $189.60, placing the stock +2.3% above today's low and -0.4% off the high.

Danaher(DHR) shares are trading with a volume of 4.46M, against a daily average of 4.31M.

In the last year, Danaher(DHR) shares hit a 52-week high of $242.80 and a 52-week low of $171.00.

In the last year, Danaher(DHR) shares hit a 52-week high of $242.80 and a 52-week low of $171.00.

DHR News

Simply Wall St 16h
Is Danaher’s BIO-Europe Spring Focus Sharpening Its Life Sciences Edge or Simply Polishing the Story?

Danaher Corporation recently presented at the BIO-Europe Spring 2026 conference in Lisbon on March 24, 2026, with Senior Director Luciano Lucas speaking to an a...

Is Danaher’s BIO-Europe Spring Focus Sharpening Its Life Sciences Edge or Simply Polishing the Story?
Simply Wall St 3d
A Look At Danaher Valuation After Recent Share Price Weakness

Advertisement Why Danaher (DHR) Is Drawing Attention Now Danaher (DHR) is back on many watchlists after a period of weaker share performance, including a 13%...

A Look At Danaher Valuation After Recent Share Price Weakness
Nasdaq 5d
Danaher Achieves #26 Analyst Rank, Surpassing Insulet

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Danaher Corp (Symbol: DHR) has taken over the #26 s...

Danaher Achieves #26 Analyst Rank, Surpassing Insulet

Analyst ratings

85%

of 27 ratings
Buy
85.2%
Hold
14.8%
Sell
0%

More DHR News

Nasdaq 5d
S&P 500 Analyst Moves: DHR

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Danaher is now the #71 analyst pick,...

S&P 500 Analyst Moves: DHR

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.